Molecular Point-of-care testing Market - Forecast(2024 - 2030)

1. Global Molecular POCT Market- Market Overview

    1.1 Definitions and Scope

2. Global Molecular POCT Market - Executive Summary

    2.1 Market Revenue, Market Size and Key Trends by Company

    2.2 Key trends by Application

    2.3 Key trends by Geography

3. Global Molecular POCT Market – Landscape

    3.1 Market Share Analysis- Top Companies

    3.2 Product Benchmarking- Top Companies

    3.3 Top 5 Financials Analysis

    3.4 Patent Analysis- Top Companies

    3.5 Pricing Analysis

        3.5.1 By Test and By Player

        3.5.2 By POCT Instruments and By Player

4. Global Molecular POCT Market - Startup companies Scenario Premium Premium

    4.1 Top startup company Analysis by

        4.1.1 Investment

        4.1.2 Revenue

        4.1.3 Application Analysis

        4.1.4 Venture Capital and Funding Scenario

5. Global Molecular POCT Market – Industry Market Entry Scenario Premium Premium

    5.1 Regulatory Framework Overview

    5.2 New Business and Ease of Doing business index

    5.3 Successful venture profiles

    5.4 Customer Analysis – Top companies

6. Global Molecular POCT Market - Market Forces

    6.1 Market Drivers

    6.2 Market Constraints

    6.3 Market Opportunities

    6.4 Porters five force model

        6.4.1 Bargaining power of suppliers

        6.4.2 Bargaining powers of customers

        6.4.3 Threat of new entrants

        6.4.4 Rivalry among existing players

        6.4.5 Threat of substitutes

7. Global Molecular POCT Market – Strategic Analysis

    7.1 Value Chain Analysis

    7.2 Opportunity Analysis

    7.3 Product Life Cycle

    7.4 Supplier and Distributor

8. Global Molecular POCT Market- By Product and Services (Market Size-$M)

    8.1 Assays & Kits

    8.2 Instruments/Analyzers

    8.3 Software & Services

9. Global Molecular POCT Market- By Indications (Market Size-$M)

    9.1 Respiratory

        9.1.1 Covid-19

        9.1.2 Flu A

        9.1.3 Flu B

        9.1.4 RSV

    9.2 STI

        9.2.1 CT

        9.2.2 NG

        9.2.3 UU

        9.2.4 MG

        9.2.5 MH

        9.2.6 Others

    9.3 HPV

    9.4 Gastrointestinal Tract

        9.4.1 Shiga Toxin

        9.4.2 H.Pylori

        9.4.3 Group B Streptococcus

    9.5 Tuberculosis

    9.6 Pneumonia

    9.7 Others

10. Global Molecular POCT Market – By End Use (Market Size -$Million)

    10.1 Physician Offices

    10.2 Hospital Emergency & ICUs

    10.3 Research Institutes

    10.4 Others

11. Global Molecular POCT Market - By Geography (Market Size -$Million)

    11.1 Key Players Annual Test Volumes – By Country

    11.2 Number of POCT Instruments Installed – By Country

    11.3 North America

        11.3.1 U.S

        11.3.2 Canada

    11.4 Europe

        11.4.1 UK

        11.4.2 Germany

        11.4.3 France

        11.4.4 Italy

        11.4.5 Spain

        11.4.6 Rest of Europe

    11.5 Middle East

        11.5.1 Saudi Arabia

        11.5.2 UAE

        11.5.3 Israel

        11.5.4 Rest of Middle East

    11.6 Africa

        11.6.1 South Africa

        11.6.2 Kenya

        11.6.3 Nigeria

        11.6.4 Rest of Africa

    11.7 South East Asia

        11.7.1 Singapore

        11.7.2 Malaysia

        11.7.3 Philippines

        11.7.4 Vietnam

        11.7.5 Thailand

        11.7.6 Rest of SEA

    11.8 South Asia

        11.8.1 India

        11.8.2 Bangladesh

        11.8.3 Pakistan

        11.8.4 Rest of South Asia

12. Global Molecular POCT Market – Entropy

    12.1 New Product Launches

    12.2 M&As, Collaborations, JVs and Partnerships

13. Global Molecular POCT Market Company Analysis (Company Revenue, Products, M&A, Developments)

    13.1 Lucira

    13.2 Mesa BioTech

    13.3 BinX

    13.4 Abbott

    13.5 Cepheid

    13.6 Genepoc

    13.7 Mobidiaq

    13.8 Q-POC

    13.9 Company 9

    13.10 Company 10 and more

"*Financials would be provided on a best efforts basis for private companies*"